13F data as of 2025-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/WINT

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

Filings (14d)

Data as of 2026-07-22

2026-07-22

On December 16, 2025, Windtree Therapeutics signed an agreement to sell its cardiovascular drug candidates to Seismic Pharmaceutical Operations (SPO). Windtree is entitled to 20% of any future proceeds SPO receives, including global commercial net revenue from the acute heart failure treatment if approved. If SPO raises at least $10 million in financing to develop the assets, Windtree will receive a $700,000 payment. Windtree will also transfer certain development payables related to these candidates to SPO.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

97382D600

FAQ

Who are the top institutional investors holding WINDTREE THERAPEUTICS INC (WINT)?

Major stakeholders currently include Jane Street Group, LLC ($7.5K), Tower Research Capital LLC (TRC) ($1.1K), Bank Of America CORP /de/ ($53.0). Based on the latest 13F filings, there are a total of 6 tracked investment funds and institutions maintaining positions in WINT.

What is the overall institutional sentiment toward WINT recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $29.4K, driven by 1 managers accumulating shares while 0 reduced their exposure.

Which institutions have been selling or reducing their WINT positions?

In the latest period, no tracked funds trimmed or exited their positions in WINT.

Are there any notable investors adding WINT to their portfolios?

Yes, buying activity remains notable. 0 institutions opened new positions in {ticker}, and 1 existing holders added to their shares. The total reported buy value for the quarter amounted to $53.0.

Related Stocks

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,153

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,960

Total reported value

$1.5T

3030 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,769

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access WINT's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/WINT

CLI

npx alphasmo stocks get WINT

Full API & MCP documentation →